Literature DB >> 1287662

Oxygen binding and other physical properties of human hemoglobin made in yeast.

K Adachi1, P Konitzer, C H Lai, J Kim, S Surrey.   

Abstract

Wagenbach et al. (1991, BioTechnology, 9, 57-61) have recently developed a system for producing soluble recombinant tetrameric hemoglobin in yeast: hemoglobin begins to appear 4-5 h after induction with galactose, alpha- and beta-globin chains fold in vivo and endogeneously produced heme is incorporated into hemoglobin tetramers. We have further characterized the oxygen-binding properties, as well as the tetramer stability, of recombinant human Hb A made in yeast. After purification by ion-exchange chromatography, a single band at the same position as normal human Hb A was obtained using cellulose acetate electrophoresis. Although the oxy and deoxy forms of purified recombinant Hb A made in yeast were spectrophotometrically identical to native human Hb A, the oxygen-binding curve was shifted slightly left of that for native human Hb A. Further purification of recombinant hemoglobin by FPLC revealed two fractions: one (fraction B) with low cooperativity and high oxygen affinity, and the other (fraction A) with almost identical cooperativity and oxygen affinity compared with native human Hb A. The Bohr effect of fraction A was also identical to native human Hb A. Hemoglobin in fraction B with lowered cooperativity precipitated approximately 1.5 times faster than normal human Hb A during mechanical agitation, while hemoglobin in fraction A with normal cooperativity precipitated with kinetics identical to native human Hb A. These results suggest that some of the recombinant molecules made in yeast fold improperly, and that these molecules may exhibit decreased cooperativity for oxygen binding and decreased stability.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1287662     DOI: 10.1093/protein/5.8.807

Source DB:  PubMed          Journal:  Protein Eng        ISSN: 0269-2139


  6 in total

Review 1.  Development of recombinant hemoglobin-based oxygen carriers.

Authors:  Cornelius L Varnado; Todd L Mollan; Ivan Birukou; Bryan J Z Smith; Douglas P Henderson; John S Olson
Journal:  Antioxid Redox Signal       Date:  2012-11-16       Impact factor: 8.401

2.  A human embryonic hemoglobin inhibits Hb S polymerization in vitro and restores a normal phenotype to mouse models of sickle cell disease.

Authors:  Zhenning He; J Eric Russell
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-17       Impact factor: 11.205

3.  Production of human embryonic haemoglobin (Gower II) in a yeast expression system.

Authors:  R M Mould; O M Hofmann; T Brittain
Journal:  Biochem J       Date:  1994-03-15       Impact factor: 3.857

4.  Properties of a recombinant human hemoglobin double mutant: sickle hemoglobin with Leu-88(beta) at the primary aggregation site substituted by Ala.

Authors:  J J Martin de Llano; J M Manning
Journal:  Protein Sci       Date:  1994-08       Impact factor: 6.725

5.  Mutational analysis of phenylalanine beta 85 in the valine beta 6 acceptor pocket during hemoglobin S polymerization.

Authors:  K Adachi; L R Reddy; K S Reddy; S Surrey
Journal:  Protein Sci       Date:  1995-07       Impact factor: 6.725

6.  Regulation and Maturation of the Shewanella oneidensis Sulfite Reductase SirA.

Authors:  Kenneth L Brockman; Sheetal Shirodkar; Trevor J Croft; Rini Banerjee; Daad A Saffarini
Journal:  Sci Rep       Date:  2020-01-22       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.